StellarGene

Delhi, India Founded: 2016 • Age: 10 yrs
Provides comprehensive genetic testing solutions for accurate gene analysis and personalized health insights.
Annual revenue $673 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About StellarGene

StellarGene is a company based in Delhi (India) founded in 2016. It operates as a B2B. StellarGene operates in a competitive market with competitors including 23andMe, Helix, DDC Paternity Tests, Asa Rén and EONE Diagnomics Genome Center, among others.

Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $673.18 (USD)
    0
    as on Mar 31, 2017
  • Net Profit
    -$202.96 (USD)
    0
    as on Mar 31, 2017
  • EBITDA
    $46.97 (USD)
    0
    as on Mar 31, 2017
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of StellarGene

Premium access

Detailed funding history for StellarGene

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by StellarGene

Investments
Premium access

Investment portfolio details for StellarGene

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - StellarGene

Premium access

Detailed financials for StellarGene

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Stellargene Comparisons

StellarGene Primary company
Description
Provides comprehensive genetic testing solutions for accurat...
Location
Delhi, India
Founded Year
2016
Annual Revenue
$673.18 (USD)
Net Profit
-$202.96 (USD)
EBITDA
$46.97 (USD)
Employees
Not available
Premium access

Peer comparison for StellarGene

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of StellarGene

StellarGene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 23andMe, Helix, DDC Paternity Tests, Asa Rén and EONE Diagnomics Genome Center, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
Locked Locked Locked
Genomic database for clinical research is provided.
Locked Locked Locked
DNA tests and personalized diagnostics are provided for various specialties.
Locked Locked Locked
AI-powered platform for precision medicine and longevity research is developed.
Locked Locked Locked
Genomics-based diagnostic services are developed for health screening and assessment.
Locked Locked Locked
Novel sequencing technologies for NGS-based genome analysis are developed.
Premium access

Detailed competitors of StellarGene

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Stellargene

Premium access

Complete news archive for StellarGene

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about StellarGene

StellarGene was founded in 2016.

StellarGene is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Annual revenue of StellarGene is $673.18 as on Mar 31, 2017.

StellarGene provides comprehensive genetic testing solutions for accurate gene analysis and personalized health insights, focusing on providing healthcare solutions, advancing biotech innovations, genetic testing, and gene analysis services. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

StellarGene's top competitors include 23andMe, Helix and DDC Paternity Tests.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available